nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—CHRM3—ureter—cervical cancer	0.0664	0.209	CbGeAlD
Loxapine—CHRM3—exocrine gland—cervical cancer	0.0131	0.0411	CbGeAlD
Loxapine—CHRM5—epithelium—cervical cancer	0.0102	0.032	CbGeAlD
Loxapine—HTR1E—female gonad—cervical cancer	0.01	0.0315	CbGeAlD
Loxapine—ADRA1B—renal system—cervical cancer	0.00863	0.0271	CbGeAlD
Loxapine—DRD5—female reproductive system—cervical cancer	0.00843	0.0265	CbGeAlD
Loxapine—DRD5—female gonad—cervical cancer	0.00767	0.0241	CbGeAlD
Loxapine—HTR7—epithelium—cervical cancer	0.00542	0.017	CbGeAlD
Loxapine—SLC6A2—decidua—cervical cancer	0.00531	0.0167	CbGeAlD
Loxapine—CHRM3—renal system—cervical cancer	0.00528	0.0166	CbGeAlD
Loxapine—HTR1A—renal system—cervical cancer	0.00526	0.0165	CbGeAlD
Loxapine—ADRA1A—epithelium—cervical cancer	0.00523	0.0164	CbGeAlD
Loxapine—HTR1B—female reproductive system—cervical cancer	0.00522	0.0164	CbGeAlD
Loxapine—HTR1D—female reproductive system—cervical cancer	0.00506	0.0159	CbGeAlD
Loxapine—HTR7—renal system—cervical cancer	0.00503	0.0158	CbGeAlD
Loxapine—HTR2C—female reproductive system—cervical cancer	0.00501	0.0157	CbGeAlD
Loxapine—ADRA2C—uterine cervix—cervical cancer	0.00494	0.0155	CbGeAlD
Loxapine—ADRB1—female reproductive system—cervical cancer	0.00491	0.0154	CbGeAlD
Loxapine—ADRA1A—renal system—cervical cancer	0.00485	0.0152	CbGeAlD
Loxapine—SLC6A4—female reproductive system—cervical cancer	0.00475	0.0149	CbGeAlD
Loxapine—CHRM1—female reproductive system—cervical cancer	0.00473	0.0148	CbGeAlD
Loxapine—ADRA2C—decidua—cervical cancer	0.00471	0.0148	CbGeAlD
Loxapine—HRH2—lymph node—cervical cancer	0.00463	0.0145	CbGeAlD
Loxapine—ADRA2C—renal system—cervical cancer	0.00462	0.0145	CbGeAlD
Loxapine—ADRA2C—endometrium—cervical cancer	0.00447	0.014	CbGeAlD
Loxapine—ADRA2C—mammalian vulva—cervical cancer	0.00432	0.0136	CbGeAlD
Loxapine—CHRM3—female reproductive system—cervical cancer	0.00423	0.0133	CbGeAlD
Loxapine—SLC6A2—female reproductive system—cervical cancer	0.00418	0.0131	CbGeAlD
Loxapine—ADRA2C—uterus—cervical cancer	0.00412	0.0129	CbGeAlD
Loxapine—HRH1—epithelium—cervical cancer	0.00405	0.0127	CbGeAlD
Loxapine—HTR7—female reproductive system—cervical cancer	0.00403	0.0126	CbGeAlD
Loxapine—HRH1—uterine cervix—cervical cancer	0.00401	0.0126	CbGeAlD
Loxapine—ADRA2A—uterine cervix—cervical cancer	0.00394	0.0124	CbGeAlD
Loxapine—CHRM3—female gonad—cervical cancer	0.00385	0.0121	CbGeAlD
Loxapine—HRH1—decidua—cervical cancer	0.00382	0.012	CbGeAlD
Loxapine—ADRA2A—decidua—cervical cancer	0.00376	0.0118	CbGeAlD
Loxapine—HRH1—endometrium—cervical cancer	0.00363	0.0114	CbGeAlD
Loxapine—ADRA2A—endometrium—cervical cancer	0.00357	0.0112	CbGeAlD
Loxapine—HRH1—mammalian vulva—cervical cancer	0.00351	0.011	CbGeAlD
Loxapine—ADRA2A—mammalian vulva—cervical cancer	0.00345	0.0108	CbGeAlD
Loxapine—HTR2A—epithelium—cervical cancer	0.00338	0.0106	CbGeAlD
Loxapine—ADRA2C—female gonad—cervical cancer	0.00337	0.0106	CbGeAlD
Loxapine—ADRA2C—vagina—cervical cancer	0.00335	0.0105	CbGeAlD
Loxapine—ADRA2A—uterus—cervical cancer	0.00329	0.0103	CbGeAlD
Loxapine—HTR2A—renal system—cervical cancer	0.00314	0.00984	CbGeAlD
Loxapine—HRH1—female reproductive system—cervical cancer	0.00301	0.00944	CbGeAlD
Loxapine—ADRA2A—female reproductive system—cervical cancer	0.00295	0.00927	CbGeAlD
Loxapine—HRH1—female gonad—cervical cancer	0.00274	0.00859	CbGeAlD
Loxapine—HRH1—vagina—cervical cancer	0.00272	0.00854	CbGeAlD
Loxapine—ADRA2A—female gonad—cervical cancer	0.00269	0.00844	CbGeAlD
Loxapine—ADRA2A—vagina—cervical cancer	0.00267	0.00838	CbGeAlD
Loxapine—HTR2A—female reproductive system—cervical cancer	0.00251	0.00788	CbGeAlD
Loxapine—SLC6A2—lymph node—cervical cancer	0.00244	0.00767	CbGeAlD
Loxapine—HTR2A—vagina—cervical cancer	0.00227	0.00713	CbGeAlD
Loxapine—ADRA2C—lymph node—cervical cancer	0.00217	0.0068	CbGeAlD
Loxapine—HRH1—lymph node—cervical cancer	0.00176	0.00552	CbGeAlD
Loxapine—ADRA2A—lymph node—cervical cancer	0.00173	0.00542	CbGeAlD
Loxapine—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.00011	0.000162	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TERT—cervical cancer	0.000109	0.000161	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000109	0.00016	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—MTOR—cervical cancer	0.000108	0.000159	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000108	0.000159	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—STAT3—cervical cancer	0.000108	0.000159	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—CTNNB1—cervical cancer	0.000108	0.000158	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	0.000108	0.000158	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—MTOR—cervical cancer	0.000108	0.000158	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—FGFR3—cervical cancer	0.000107	0.000157	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000106	0.000156	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000105	0.000155	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	0.000105	0.000154	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000104	0.000153	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000104	0.000152	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—TP53—cervical cancer	0.000104	0.000152	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000102	0.000149	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.0001	0.000147	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	0.0001	0.000147	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—CASP3—cervical cancer	9.98e-05	0.000146	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TERT—cervical cancer	9.97e-05	0.000146	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—CASP3—cervical cancer	9.91e-05	0.000145	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—EGFR—cervical cancer	9.89e-05	0.000145	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TERT—cervical cancer	9.88e-05	0.000145	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—EGFR—cervical cancer	9.88e-05	0.000145	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—EGFR—cervical cancer	9.82e-05	0.000144	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—EGFR—cervical cancer	9.81e-05	0.000144	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—MTHFR—cervical cancer	9.8e-05	0.000144	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—CTNNB1—cervical cancer	9.62e-05	0.000141	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—EGFR—cervical cancer	9.61e-05	0.000141	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—HES1—cervical cancer	9.56e-05	0.00014	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	9.56e-05	0.00014	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—CTNNB1—cervical cancer	9.55e-05	0.00014	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TERT—cervical cancer	9.54e-05	0.00014	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TERT—cervical cancer	9.49e-05	0.000139	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—EGFR—cervical cancer	9.46e-05	0.000139	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NOTCH1—cervical cancer	9.43e-05	0.000138	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—STAT3—cervical cancer	9.41e-05	0.000138	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—HES1—cervical cancer	9.4e-05	0.000138	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—HES1—cervical cancer	9.38e-05	0.000138	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—HES1—cervical cancer	9.35e-05	0.000137	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—EGFR—cervical cancer	9.33e-05	0.000137	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—HES1—cervical cancer	9.32e-05	0.000137	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—HES1—cervical cancer	9.23e-05	0.000135	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TERT—cervical cancer	9.23e-05	0.000135	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—HES1—cervical cancer	9.21e-05	0.000135	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—FGFR3—cervical cancer	9.15e-05	0.000134	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TERT—cervical cancer	9.08e-05	0.000133	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	9.07e-05	0.000133	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—MTHFR—cervical cancer	8.99e-05	0.000132	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—EGFR—cervical cancer	8.93e-05	0.000131	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	8.75e-05	0.000128	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	8.71e-05	0.000128	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	8.59e-05	0.000126	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HES1—cervical cancer	8.55e-05	0.000126	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—EGFR—cervical cancer	8.55e-05	0.000126	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—EGFR—cervical cancer	8.51e-05	0.000125	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	8.51e-05	0.000125	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	8.47e-05	0.000124	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—TP53—cervical cancer	8.42e-05	0.000124	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—EGFR—cervical cancer	8.4e-05	0.000123	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—STAT3—cervical cancer	8.38e-05	0.000123	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TERT—cervical cancer	8.37e-05	0.000123	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	8.33e-05	0.000122	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—STAT3—cervical cancer	8.33e-05	0.000122	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MTOR—cervical cancer	8.32e-05	0.000122	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MTOR—cervical cancer	8.31e-05	0.000122	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MTOR—cervical cancer	8.25e-05	0.000121	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—TP53—cervical cancer	8.25e-05	0.000121	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TERT—cervical cancer	8.24e-05	0.000121	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TERT—cervical cancer	8.22e-05	0.000121	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	8.22e-05	0.000121	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TERT—cervical cancer	8.2e-05	0.00012	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	8.17e-05	0.00012	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TERT—cervical cancer	8.17e-05	0.00012	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TERT—cervical cancer	8.09e-05	0.000119	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MTOR—cervical cancer	8.08e-05	0.000119	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TERT—cervical cancer	8.07e-05	0.000118	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MTOR—cervical cancer	7.95e-05	0.000117	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	7.95e-05	0.000117	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MTOR—cervical cancer	7.85e-05	0.000115	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	7.83e-05	0.000115	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—FGFR3—cervical cancer	7.68e-05	0.000113	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—EGFR—cervical cancer	7.65e-05	0.000112	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—CASP3—cervical cancer	7.65e-05	0.000112	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—CASP3—cervical cancer	7.64e-05	0.000112	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—EGFR—cervical cancer	7.62e-05	0.000112	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CASP3—cervical cancer	7.59e-05	0.000111	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	7.58e-05	0.000111	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—EGFR—cervical cancer	7.57e-05	0.000111	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	7.56e-05	0.000111	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—FGFR3—cervical cancer	7.54e-05	0.000111	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—FGFR3—cervical cancer	7.52e-05	0.00011	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MTOR—cervical cancer	7.51e-05	0.00011	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—FGFR3—cervical cancer	7.5e-05	0.00011	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TERT—cervical cancer	7.5e-05	0.00011	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CASP3—cervical cancer	7.43e-05	0.000109	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	7.42e-05	0.000109	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	7.4e-05	0.000109	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—CTNNB1—cervical cancer	7.37e-05	0.000108	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—CTNNB1—cervical cancer	7.37e-05	0.000108	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	7.32e-05	0.000107	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	7.32e-05	0.000107	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CASP3—cervical cancer	7.32e-05	0.000107	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	7.28e-05	0.000107	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CASP3—cervical cancer	7.22e-05	0.000106	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	7.21e-05	0.000106	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—TP53—cervical cancer	7.18e-05	0.000105	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	7.17e-05	0.000105	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MTOR—cervical cancer	7.16e-05	0.000105	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	7.1e-05	0.000104	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	7.08e-05	0.000104	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	7.08e-05	0.000104	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MTOR—cervical cancer	7.06e-05	0.000104	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	7.06e-05	0.000104	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CTNNB1—cervical cancer	7.05e-05	0.000103	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	7.04e-05	0.000103	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	6.97e-05	0.000102	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	6.97e-05	0.000102	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	6.96e-05	0.000102	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	6.95e-05	0.000102	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CASP3—cervical cancer	6.91e-05	0.000101	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	6.88e-05	0.000101	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	6.66e-05	9.78e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CASP3—cervical cancer	6.59e-05	9.67e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CASP3—cervical cancer	6.5e-05	9.54e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	6.46e-05	9.48e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MTOR—cervical cancer	6.44e-05	9.45e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—STAT3—cervical cancer	6.43e-05	9.43e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—EGFR—cervical cancer	6.43e-05	9.43e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—STAT3—cervical cancer	6.42e-05	9.42e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—cervical cancer	6.4e-05	9.39e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—STAT3—cervical cancer	6.38e-05	9.36e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MTOR—cervical cancer	6.38e-05	9.36e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—cervical cancer	6.36e-05	9.33e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	6.35e-05	9.32e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	6.32e-05	9.28e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—EGFR—cervical cancer	6.31e-05	9.26e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—EGFR—cervical cancer	6.29e-05	9.23e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—EGFR—cervical cancer	6.27e-05	9.2e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CTNNB1—cervical cancer	6.26e-05	9.19e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—STAT3—cervical cancer	6.25e-05	9.17e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	6.21e-05	9.11e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	6.19e-05	9.09e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MTOR—cervical cancer	6.16e-05	9.04e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—STAT3—cervical cancer	6.15e-05	9.02e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MTOR—cervical cancer	6.13e-05	8.99e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—STAT3—cervical cancer	6.06e-05	8.9e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MTOR—cervical cancer	5.96e-05	8.74e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CASP3—cervical cancer	5.92e-05	8.69e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CASP3—cervical cancer	5.87e-05	8.61e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	5.86e-05	8.61e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—EGFR—cervical cancer	5.84e-05	8.57e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—EGFR—cervical cancer	5.84e-05	8.56e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—STAT3—cervical cancer	5.81e-05	8.52e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—EGFR—cervical cancer	5.8e-05	8.51e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	5.75e-05	8.44e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	5.71e-05	8.38e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—EGFR—cervical cancer	5.68e-05	8.33e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CASP3—cervical cancer	5.66e-05	8.31e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	5.65e-05	8.3e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CASP3—cervical cancer	5.63e-05	8.27e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—EGFR—cervical cancer	5.59e-05	8.2e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—STAT3—cervical cancer	5.53e-05	8.12e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EGFR—cervical cancer	5.51e-05	8.09e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CASP3—cervical cancer	5.48e-05	8.04e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—STAT3—cervical cancer	5.46e-05	8.01e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	5.46e-05	8.01e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	5.43e-05	7.97e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MTOR—cervical cancer	5.41e-05	7.93e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	5.39e-05	7.91e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MTOR—cervical cancer	5.32e-05	7.81e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MTOR—cervical cancer	5.31e-05	7.79e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MTOR—cervical cancer	5.29e-05	7.76e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	5.28e-05	7.75e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EGFR—cervical cancer	5.28e-05	7.75e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MTOR—cervical cancer	5.27e-05	7.74e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MTOR—cervical cancer	5.22e-05	7.66e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	5.21e-05	7.64e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	5.2e-05	7.63e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EGFR—cervical cancer	5.03e-05	7.38e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—STAT3—cervical cancer	4.97e-05	7.3e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CASP3—cervical cancer	4.97e-05	7.3e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EGFR—cervical cancer	4.96e-05	7.28e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—STAT3—cervical cancer	4.93e-05	7.23e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—cervical cancer	4.91e-05	7.2e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—cervical cancer	4.9e-05	7.19e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CASP3—cervical cancer	4.89e-05	7.18e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CASP3—cervical cancer	4.88e-05	7.16e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—cervical cancer	4.87e-05	7.14e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CASP3—cervical cancer	4.87e-05	7.14e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CASP3—cervical cancer	4.85e-05	7.12e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	4.84e-05	7.1e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CASP3—cervical cancer	4.8e-05	7.05e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	4.79e-05	7.03e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	4.79e-05	7.03e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—cervical cancer	4.77e-05	7e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—STAT3—cervical cancer	4.76e-05	6.98e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—STAT3—cervical cancer	4.73e-05	6.95e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	4.72e-05	6.92e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	4.71e-05	6.91e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	4.69e-05	6.88e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—cervical cancer	4.69e-05	6.88e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	4.68e-05	6.86e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	4.63e-05	6.8e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—cervical cancer	4.63e-05	6.79e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	4.62e-05	6.78e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—STAT3—cervical cancer	4.6e-05	6.76e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	4.53e-05	6.65e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EGFR—cervical cancer	4.52e-05	6.64e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EGFR—cervical cancer	4.48e-05	6.57e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	4.45e-05	6.53e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—cervical cancer	4.43e-05	6.5e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EGFR—cervical cancer	4.32e-05	6.35e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EGFR—cervical cancer	4.3e-05	6.31e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	4.29e-05	6.3e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—cervical cancer	4.22e-05	6.2e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EGFR—cervical cancer	4.18e-05	6.14e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—STAT3—cervical cancer	4.18e-05	6.13e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—cervical cancer	4.17e-05	6.11e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	4.12e-05	6.04e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—STAT3—cervical cancer	4.11e-05	6.03e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—STAT3—cervical cancer	4.1e-05	6.02e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—STAT3—cervical cancer	4.09e-05	6e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—STAT3—cervical cancer	4.08e-05	5.98e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—STAT3—cervical cancer	4.04e-05	5.92e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	4.03e-05	5.91e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EGFR—cervical cancer	3.8e-05	5.57e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—cervical cancer	3.8e-05	5.57e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—cervical cancer	3.76e-05	5.52e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	3.74e-05	5.49e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EGFR—cervical cancer	3.74e-05	5.48e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EGFR—cervical cancer	3.73e-05	5.47e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EGFR—cervical cancer	3.72e-05	5.45e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EGFR—cervical cancer	3.7e-05	5.44e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EGFR—cervical cancer	3.67e-05	5.38e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	3.66e-05	5.37e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—cervical cancer	3.63e-05	5.33e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—cervical cancer	3.61e-05	5.3e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—cervical cancer	3.51e-05	5.16e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—cervical cancer	3.46e-05	5.07e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	3.4e-05	4.99e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—cervical cancer	3.19e-05	4.68e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—cervical cancer	3.14e-05	4.6e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—cervical cancer	3.13e-05	4.59e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—cervical cancer	3.12e-05	4.58e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—cervical cancer	3.11e-05	4.56e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—cervical cancer	3.08e-05	4.52e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—cervical cancer	3.07e-05	4.51e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—cervical cancer	2.85e-05	4.19e-05	CbGpPWpGaD
